Episode Details

1.      Excellent paper on harmonization of performing and reporting MRD in multiple myeloma:
         https://www.nature.com/articles/s41375-020-01012-4

2.     Does CR really matter in the era of MRD? Landmark paper from the Spanish Group:
        https://pubmed.ncbi.nlm.nih.gov/35560160/

3.     Meta-analysis showing individual-level prognostic impact of MRD on long-term outcomes in multiple myeloma:
        https://pubmed.ncbi.nlm.nih.gov/33284948/

4.     MASTER Trial-The first trial testing MRD-adapted treatment strategy in multiple myeloma :
        https://pubmed.ncbi.nlm.nih.gov/34898239/